Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seville
Clinical trial register · Spain

Clinical Trials in Seville, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 80 Madrid 65 Seville 37 Valencia 34 Málaga 18
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca71 Hoffmann-La Roche48 Merck Sharp & Dohme LLC47 Janssen Research & Development, LLC40 Eli Lilly and Company37 Clear sponsor filter
Site location
Barcelona80 Madrid65 Seville37 Valencia34 Málaga18
All 78 locations
Target enrolment
to

Trials with a site in Seville

37 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Eli Lilly and Company
Phase 3
150
Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
2026-09
Not yet open
Eli Lilly and Company
Phase 3
170
Barcelona, Málaga, Seville
2026-09
Recruiting
Eli Lilly and Company
Phase 3
2,001
Alcobendas, Barcelona, Centelles, Ferrol, Granada, Madrid, Pozuelo de Alarcón, Seville
2026-08-26
Recruiting
Eli Lilly and Company
Phase 3
1,000
Barcelona, Centelles, Madrid, Oviedo, Salamanca, Seville, Zamora
2026-08-14
Recruiting
Eli Lilly and Company
Phase 3
252
A Coruña, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Seville, Valencia
2026-06-01
Recruiting
Eli Lilly and Company
Phase 4
150
Santander, Seville
2026-03-09
Recruiting
Eli Lilly and Company
Phase 3
900
A Coruña, Almería, Barcelona, Ferrol, Palma de Mallorca, Pozuelo de Alarcón, Santander, Seville
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
800
Guadalajara, Lleida, Logroño, Madrid, Málaga, Seville
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
300
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Santander, Seville, Valencia
2026-02-05
Recruiting
Eli Lilly and Company
Phase 3
1,035
Alzira, Barcelona, Madrid, Málaga, Santiago de Compostela, Seville
2025-12-15
Active, closed
Eli Lilly and Company
Phase 3
800
A Coruña, Barcelona, Málaga, Santander, Santiago de Compostela, Seville, Valladolid
2025-09-15
Recruiting
Eli Lilly and Company
Phase 3
290
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Active, closed
Eli Lilly and Company
Phase 3
465
Badajoz, Badalona, Barcelona, Madrid, Seville
2025-05-12
Active, closed
Eli Lilly and Company
Phase 3
487
A Coruña, Barcelona, Centelles, León, Seville
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
A Coruña, Barcelona, Centelles, León, Seville
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
A Coruña, Barcelona, Centelles, León, Seville
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
905
A Coruña, Barcelona, Ferrol, Móstoles, Santander, Seville
2025-04-25
Recruiting
Eli Lilly and Company
Phase 3
125
Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
2024-11-18
Active, closed
Eli Lilly and Company
Phase 2
45
Barcelona, Córdoba, Esplugues de Llobregat, Madrid, Seville, Valencia
2024-10-25
Active, closed
Eli Lilly and Company
Phase 3
1,400
Barcelona, Pozuelo de Alarcón, San Sebastián, Seville
2024-10-24
Active, closed
Eli Lilly and Company
Phase 2
143
Barcelona, Ciudad Real, Córdoba, Huelva, Las Palmas de GC, Madrid, Santiago de Compostela, Seville
2024-10-10
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT06465069Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
420
Barcelona, Madrid, Seville
2024-07-01
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Barcelona, Madrid, Seville
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
3,127
A Coruña, Ferrol, Almería, Málaga, Seville, Badalona, Barcelona, Valladolid
2023-06-05
Recruiting
Eli Lilly and Company
Phase 1/2
880
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Seville
2023-04-17
Active, closed
Eli Lilly and Company
Phase 2
46
Barcelona, Esplugues de Llobregat, Madrid, Seville, Valencia
2022-09-20
Active, closed
Eli Lilly and Company
Phase 3
925
Hospitalet, Madrid, Valencia, Badajoz, Seville
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
874
Barcelona, Cáceres, Lleida, Madrid, San Cristóbal de La Laguna, Valencia, Granada, Seville
2021-10-04
Active, closed
Eli Lilly and Company
Phase 3
101
Esplugues de Llobregat, Madrid, Málaga, Seville, Valencia
2021-04-13
Active, closed
Eli Lilly and Company
Phase 3
312
Barcelona, Seville, Valencia, Valladolid
2020-11-25
Active, closed
Eli Lilly and Company
Phase 3
58
Esplugues de Llobregat, Madrid, Seville, Valencia
2020-02-12
Recruiting
Eli Lilly and Company
Phase 2
105
Barcelona, Esplugues de Llobregat, Madrid, San Cristóbal de La Laguna, Seville, Valencia
2020-01-22
Recruiting
Eli Lilly and Company
Phase 3
190
Esplugues de Llobregat, Madrid, Seville, Valencia
2019-04-05
Active, closed
Eli Lilly and Company
Phase 3
533
Barcelona, Seville, Valencia, Valladolid
2018-03-14
Active, closed
Eli Lilly and Company
Phase 3
545
Barcelona, Hospitalet, Palma, Pozuelo de Alarcón, Madrid, Pamplona, Seville, Valencia
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
453
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Valencia
2014-10-03
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/seville

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies with a site in Seville that also match the filters currently applied.

How many clinical trials are recruiting in Seville?

15 of the 37 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 20 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seville), 37 studies
PhaseStudiesRecruitingShare
Phase 3291178.4%
Phase 24110.8%
Phase 1215.4%
Phase 1/2112.7%
Phase 4112.7%

Most active sponsors

Lead sponsors with the most studies (Seville)
Lead sponsorStudiesRecruiting
Eli Lilly and Company3715
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.